Andrew P South

12PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 19, 2026
Viability of Tumor Cells in Bone Dust: Implications for Oncologic Skull Base Surgery.

|Sep 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena, Hani Samarah, Kathryn Nunes

|Jul 30, 2025
Partial-EMT cell state correlates with single cell pattern of invasion in head and neck SCC keratinocytes.

Pyung Hun Park, Lauren E Israel, Michael H Alexander

|May 29, 2025
Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma.

Martin Laimer, Andrew P South, Elisabeth Mayr

|Nov 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.

Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena

|Oct 10, 2024
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.

Priyan Bhattacharya, Alban Linnenbach, Andrew P South

Pageof 2

Frequent Collaborators

3 joint publications

Ubaldo Martinez-Outschoorn

3 joint publications

Larry Harshyne

3 joint publications

Joseph M Curry

3 joint publications

Stacey Gargano